NYSE:ABBV - AbbVie News Headlines

Sign in or create an account to add this stock to your watchlist.
$96.25 -0.38 (-0.39 %)
(As of 07/16/2018 04:00 PM ET)
Previous Close$96.63
Today's Range$95.26 - $96.82
52-Week Range$69.38 - $125.86
Volume3.78 million shs
Average Volume7.72 million shs
Market Capitalization$153.34 billion
P/E Ratio17.19
Dividend Yield4.02%
Beta1.61

Headlines

AbbVie (NYSE ABBV) News Headlines

Source:
DateHeadline
Jefferies Financial Group Analysts Give AbbVie (ABBV) a $100.00 Price TargetJefferies Financial Group Analysts Give AbbVie (ABBV) a $100.00 Price Target
www.americanbankingnews.com - July 16 at 9:53 AM
Biotech Analysis Central Pharma News: Zogenixs Late-Stage Win, Zynerbas Bounce Back, Abbvies Expanded Venetoclax UseBiotech Analysis Central Pharma News: Zogenix's Late-Stage Win, Zynerba's Bounce Back, Abbvie's Expanded Venetoclax Use
seekingalpha.com - July 16 at 5:12 AM
Your Daily Pharma Scoop: Zogenix Zooms, Zynerbas Changing Fortunes, AbbVie ProceedsYour Daily Pharma Scoop: Zogenix Zooms, Zynerba's Changing Fortunes, AbbVie Proceeds
seekingalpha.com - July 15 at 7:40 AM
3 Best Big Pharma Stocks to Buy for the 2nd Half of 20183 Best Big Pharma Stocks to Buy for the 2nd Half of 2018
finance.yahoo.com - July 15 at 7:40 AM
AbbVie (ABBV) Rating Increased to Hold at Credit Suisse GroupAbbVie (ABBV) Rating Increased to Hold at Credit Suisse Group
www.americanbankingnews.com - July 15 at 4:34 AM
3 Things In Biotech, July 13: AbbVie Swings, And AbbVie Also Misses3 Things In Biotech, July 13: AbbVie Swings, And AbbVie Also Misses
seekingalpha.com - July 14 at 3:20 PM
2 Overlooked Biotech Stocks to Buy Now2 Overlooked Biotech Stocks to Buy Now
finance.yahoo.com - July 14 at 3:20 PM
Pharma Stock Roundup: PFE to Split Into 3 Units, J&J to Pay $4.7B in Talc LawsuitPharma Stock Roundup: PFE to Split Into 3 Units, J&J to Pay $4.7B in Talc Lawsuit
finance.yahoo.com - July 14 at 3:20 PM
5 Big Pharma Stocks Investors Love Right Now5 Big Pharma Stocks Investors Love Right Now
finance.yahoo.com - July 14 at 3:20 PM
Will J&J's (JNJ) Pharma Segment Strength Drive Q2 Earnings?Will J&J's (JNJ) Pharma Segment Strength Drive Q2 Earnings?
finance.yahoo.com - July 14 at 3:20 PM
AbbVie’s Supplemental New Drug Application for VenetoclaxAbbVie’s Supplemental New Drug Application for Venetoclax
finance.yahoo.com - July 14 at 3:20 PM
AbbVie Announces Collaborations with Calico and CalibrAbbVie Announces Collaborations with Calico and Calibr
finance.yahoo.com - July 14 at 3:20 PM
Berenberg Starts Abbvie (ABBV) at HoldBerenberg Starts Abbvie (ABBV) at Hold
www.streetinsider.com - July 13 at 5:10 AM
AbbVie (ABBV) Reports Submission of Supplemental New Drug Application to FDA for VenetoclaxAbbVie (ABBV) Reports Submission of Supplemental New Drug Application to FDA for Venetoclax
www.streetinsider.com - July 13 at 5:10 AM
Your Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie FaltersYour Daily Pharma Scoop: ResTORbio Progresses, Roche Closer To Review, AbbVie Falters
seekingalpha.com - July 13 at 5:10 AM
Keep Your Eyes on Healthcares Odd Couple: AbbVie and AlphabetKeep Your Eyes on Healthcare's Odd Couple: AbbVie and Alphabet
finance.yahoo.com - July 13 at 5:10 AM
3 Pharma Stocks Goldman Sachs Sees as Buys3 Pharma Stocks Goldman Sachs Sees as Buys
finance.yahoo.com - July 13 at 5:10 AM
AbbVies Imbruvica Fails in Phase III Blood Cancer StudyAbbVie's Imbruvica Fails in Phase III Blood Cancer Study
www.nasdaq.com - July 12 at 3:06 PM
AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2018AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for July 12, 2018
www.nasdaq.com - July 12 at 3:06 PM
AbbVie files US marketing application for expanded use for VenclextaAbbVie files US marketing application for expanded use for Venclexta
seekingalpha.com - July 12 at 3:06 PM
J&J (JNJ) to Set Pharma Q2 Earnings in Motion: What's Up?J&J (JNJ) to Set Pharma Q2 Earnings in Motion: What's Up?
finance.yahoo.com - July 12 at 3:06 PM
AbbVie's Imbruvica Fails in Phase III Blood Cancer StudyAbbVie's Imbruvica Fails in Phase III Blood Cancer Study
finance.yahoo.com - July 12 at 3:06 PM
AbbVie (ABBV) Now Covered by Berenberg BankAbbVie (ABBV) Now Covered by Berenberg Bank
www.americanbankingnews.com - July 12 at 1:05 PM
AbbVie Announces Submission of Supplemental New...AbbVie Announces Submission of Supplemental New...
www.benzinga.com - July 12 at 5:14 AM
AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive ChemotherapyAbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
finance.yahoo.com - July 12 at 5:14 AM
[$$] The drug pricing playbook: how pharma companies keep costs high[$$] The drug pricing playbook: how pharma companies keep costs high
finance.yahoo.com - July 12 at 5:14 AM
AbbVies Imbruvica flunks late-stage DLBCL study; shares down 2% premarketAbbVie's Imbruvica flunks late-stage DLBCL study; shares down 2% premarket
seekingalpha.com - July 11 at 3:00 PM
AbbVie (ABBV) Provides Update on Phase 3 Study of Ibrutinib in Blood Cancer DLBCL and Ongoing Ibrutinib Clinical ProgramAbbVie (ABBV) Provides Update on Phase 3 Study of Ibrutinib in Blood Cancer DLBCL and Ongoing Ibrutinib Clinical Program
www.streetinsider.com - July 11 at 3:00 PM
AbbVies stock falls after lymphoma treatment trial data disappointsAbbVie's stock falls after lymphoma treatment trial data disappoints
www.marketwatch.com - July 11 at 3:00 PM
Ex-Dividend Reminder: AbbVie, Abbott Laboratories and Patterson CompaniesEx-Dividend Reminder: AbbVie, Abbott Laboratories and Patterson Companies
www.nasdaq.com - July 10 at 3:12 PM
AbbVie to Host Second-Quarter 2018 Earnings Conference CallAbbVie to Host Second-Quarter 2018 Earnings Conference Call
finance.yahoo.com - July 10 at 3:12 PM
The Zacks Analyst Blog Highlights: Apache, Continental Resources, KMG Chemicals, ZAGG and AbbVieThe Zacks Analyst Blog Highlights: Apache, Continental Resources, KMG Chemicals, ZAGG and AbbVie
finance.yahoo.com - July 10 at 3:12 PM
3 Top Biotech Stocks to Buy in July3 Top Biotech Stocks to Buy in July
finance.yahoo.com - July 7 at 5:07 AM
AbbVie Inc (ABBV) Receives Consensus Recommendation of "Hold" from BrokeragesAbbVie Inc (ABBV) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - July 6 at 4:30 PM
U.S. judge tosses $140 mln verdict against AbbVie in AndroGel caseU.S. judge tosses $140 mln verdict against AbbVie in AndroGel case
www.reuters.com - July 5 at 3:16 PM
AbbVie prevails in second AndroGel liability case; shares up 1%AbbVie prevails in second AndroGel liability case; shares up 1%
seekingalpha.com - July 5 at 3:16 PM
Heres Why AbbVie Stock is Good for Your Portfolios HealthHere's Why AbbVie Stock is Good for Your Portfolio's Health
finance.yahoo.com - July 5 at 3:15 PM
AbbVie: The Right Combination Of Dividends And GrowthAbbVie: The Right Combination Of Dividends And Growth
seekingalpha.com - July 5 at 3:15 PM
U.S. judge tosses $140 million verdict against AbbVie in AndroGel caseU.S. judge tosses $140 million verdict against AbbVie in AndroGel case
www.cnbc.com - July 5 at 3:15 PM
Here's Why AbbVie Stock is Good for Your Portfolio's HealthHere's Why AbbVie Stock is Good for Your Portfolio's Health
finance.yahoo.com - July 5 at 3:15 PM
AbbVie wins reversal of $140 mln verdict in case over AndroGel risksAbbVie wins reversal of $140 mln verdict in case over AndroGel risks
finance.yahoo.com - July 5 at 3:15 PM
[$$] AbbVie Director Makes Biggest-Ever Insider Stock Buy[$$] AbbVie Director Makes Biggest-Ever Insider Stock Buy
finance.yahoo.com - July 5 at 8:24 AM
$8.24 Billion in Sales Expected for AbbVie Inc (ABBV) This Quarter$8.24 Billion in Sales Expected for AbbVie Inc (ABBV) This Quarter
www.americanbankingnews.com - July 4 at 3:16 AM
Pfizer boosts prices of certain drugs by almost 10%Pfizer boosts prices of certain drugs by almost 10%
seekingalpha.com - July 3 at 3:05 PM
5 Great Dividend Growth Stocks to Counter Volatility5 Great Dividend Growth Stocks to Counter Volatility
finance.yahoo.com - July 3 at 3:05 PM
AstraZeneca's Two New Cancer Drugs Get Approval in JapanAstraZeneca's Two New Cancer Drugs Get Approval in Japan
finance.yahoo.com - July 3 at 3:05 PM
FDA withdraws draft guidance related to biosimilar developmentFDA withdraws draft guidance related to biosimilar development
seekingalpha.com - July 2 at 4:39 PM
Abbott Labs And Abbvie - 5 Years LaterAbbott Labs And Abbvie - 5 Years Later
seekingalpha.com - July 2 at 4:39 PM
AbbVie Is Out-Trading Its Value — Why It Could Still Be Worth MoreAbbVie Is Out-Trading Its Value — Why It Could Still Be Worth More
finance.yahoo.com - July 2 at 4:39 PM
$1.97 Earnings Per Share Expected for AbbVie Inc (ABBV) This Quarter$1.97 Earnings Per Share Expected for AbbVie Inc (ABBV) This Quarter
www.americanbankingnews.com - July 2 at 12:42 PM
This page was last updated on 7/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.